Home›Stock Screener›Poly Medicure›Quarterly Results

Poly Medicure Quarterly Results

Latest Quarter Net Profit
₹65 Cr
QMar 2026
Quarterly Results

Poly Medicure quarterly results. In Mar 2026, Poly Medicure (POLYMED) reported revenue ₹554 Cr and net profit ₹65 Cr — revenue +18.6% YoY. Check POLYMED company valuation to track the company's total market size over time.

POLYMED Quarterly Results — Revenue, Profit & EPS Highlights

Poly Medicure latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Poly Medicure screener.

  • Revenue of ₹554 Cr in Mar 2026 (-1.1% vs Jun 2026, +18.6% vs Mar 2025)
  • Net Profit of ₹65 Cr in Mar 2026 (-23.5% vs Jun 2026, -29.3% vs Mar 2025)
  • EBITDA of ₹130 Cr in Mar 2026 (-18.8% vs Jun 2026)
  • Operating Margin of 21.0% in Mar 2026 (-3.0pp vs Jun 2026)
  • Earnings Per Share of ₹6.54 in Mar 2026 (-23.0% vs Jun 2026)

Poly Medicure Quarterly Results — Revenue, EBITDA, Net Profit & EPS

POLYMED quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 554 560 479 467 447 -1.1% 18.6%
Net Profit (₹ Cr) 65 85 92 92 93 - -
EBITDA (₹ Cr) 130 160 150 146 149 - -
EPS (₹) 6.54 8.49 9.06 8.92 9.19 - -
Operating Margin (%) 21.0% 24.0% 26.0% 27.0% 26.0% - -

POLYMED Share Price Trend — 1-Year Movement Across Quarterly Results

Poly Medicure 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review POLYMED P/E comparison to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 11.7%
EBITDA Margin 23.5%
Operating Margin 21.0%
ROE (Annual) 8.3%

Balance Sheet Highlights

Total Assets ₹3,919 Cr
Total Equity ₹3,149 Cr
Current Assets ₹1,942 Cr
Current Liabilities ₹194 Cr

Cash Flow Analysis

Operating Cash Flow ₹246 Cr
Investing Cash Flow ₹-224 Cr
Financing Cash Flow ₹20 Cr
Net Cash Flow ₹43 Cr

Current Market Data

Current Price ₹1619.60
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 467
Sept 2025 479
Jun 2026 560
Mar 2026 554

Net Profit Trend (₹ Cr)

Mar 2025 92
Sept 2025 92
Jun 2026 85
Mar 2026 65

Operating Margin Trend (%)

Mar 2025 27.0%
Sept 2025 26.0%
Jun 2026 24.0%
Mar 2026 21.0%

POLYMED vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Poly Medicure latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores